A study that examines the feasibility of establishing a database that examines how genes affect opioid drug response in palliative care patients

Not Applicable

Completed

• Conditions: Cancer; Palliative Care; Pain; Genomics; Neurological - Other neurological disorders; Cancer - Any cancer; Human Genetics and Inherited Disorders - Other human genetics and inherited disorders

• Registration Number: ACTRN12619000591156
• Lead Sponsor: St Vincent’s Hospital, Melbourne

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-04-17
• Study Completion: 2021-08-31
• Last Update Posted: 13 December 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 57

Inclusion Criteria

Cancer diagnosis
Pain related to cancer and its treatment requiring opioid therapy
English speaking with sufficient reading and writing ability to complete the study questionnaires
Able and willing to give written informed consent.

Exclusion Criteria

Australian-modified Karnofsky performance score (AKPS) less than 40 at the beginning of the study

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
At least 40% of eligible participants completing all study assessments[Day 0- Day 7];The views of patients around the information and processes involved with data collection as measured by 30-minute one-on-one open-ended interview [Day 7];The views of clinicians around the information and processes involved with data collection as measured by 30-minute one-on-one open-ended interview [Day 7]